{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:07:40Z","timestamp":1792786060840,"version":"4.5.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Canada Research Chair in Pediatric Neuro-Oncology","id":[{"id":"https:\/\/ror.org\/05ghs6f64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Garron Family Cancer Chair in Childhood Cancer Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1093\/neuonc\/noag191","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:55:42Z","timestamp":1789566942000},"page":"2336-2337","source":"Crossref","is-referenced-by-count":0,"title":["BRAF-altered glioma in children and adults: From soup to nuts"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-895X","authenticated-orcid":false,"given":"Vijay","family":"Ramaswamy","sequence":"first","affiliation":[{"name":"Division of Haematology\/Oncology, Hospital for Sick Children , Toronto (V.R., U.T); , Toronto (V.R., U.T)"},{"name":"Departments of Medical Biophysics and Paediatrics, University of Toronto , Toronto (V.R., U.T); , Toronto (V.R., U.T)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5019-2683","authenticated-orcid":false,"given":"Uri","family":"Tabori","sequence":"additional","affiliation":[{"name":"Division of Haematology\/Oncology, Hospital for Sick Children , Toronto (V.R., U.T); , Toronto (V.R., U.T)"},{"name":"Departments of Medical Biophysics and Paediatrics, University of Toronto , Toronto (V.R., U.T); , Toronto (V.R., U.T)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026100502523107600_noag191-B1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/pbc.22917","article-title":"Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas","volume":"57","author":"Scheinemann","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"2026100502523107600_noag191-B2","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/cncr.29907","article-title":"Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: a population-based study","volume":"122","author":"Krishnatry","year":"2016","journal-title":"Cancer"},{"key":"2026100502523107600_noag191-B3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"key":"2026100502523107600_noag191-B4","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1172\/JCI33656","article-title":"BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas","volume":"118","author":"Pfister","year":"2008","journal-title":"J Clin Invest"},{"key":"2026100502523107600_noag191-B5","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","article-title":"Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas","volume":"68","author":"Jones","year":"2008","journal-title":"Cancer Res"},{"key":"2026100502523107600_noag191-B6","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1158\/1078-0432.CCR-19-2177","article-title":"Efficacy and safety of dabrafenib in pediatric patients with BRAF V600 mutation-positive relapsed or refractory low-grade glioma: results from a phase I\/IIa study","volume":"25","author":"Hargrave","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026100502523107600_noag191-B7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","article-title":"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial","volume":"20","author":"Fangusaro","year":"2019","journal-title":"Lancet Oncol"},{"key":"2026100502523107600_noag191-B8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-023-02668-y","article-title":"The type II RAF inhibitor tovorafenib in relapsed\/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial","volume":"30","author":"Kilburn","year":"2024","journal-title":"Nat Med"},{"key":"2026100502523107600_noag191-B9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","article-title":"Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations","volume":"389","author":"Bouffet","year":"2023","journal-title":"N Engl J Med"},{"key":"2026100502523107600_noag191-B10","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-025-00962-x","article-title":"A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis","volume":"6","author":"Bennett","year":"2025","journal-title":"Nat Cancer"},{"key":"2026100502523107600_noag191-B11","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/neuonc\/noag135","article-title":"BRAF-altered glioma in adults and children: A Society for Neuro-Oncology and European Association of Neuro-Oncology consensus review on clinical management and future directions","volume":"28","author":"Schreck","year":"2026","journal-title":"Neuro Oncol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag191\/71123107\/noag191.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/10\/2336\/71123107\/noag191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/10\/2336\/71123107\/noag191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:52:36Z","timestamp":1791183156000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/10\/2336\/8802111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":11,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,16]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag191","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,16]]}}}